RedOak readies natural-intelligence software for drug development

Cary, NC upstart RedOak Logic, now at the prototype stage with its natural intelligence software for drug development, seeks $3 million in funding. And CEO Dale Fedewa will be pitching investors this month for the funding to build the platform, collect the public data needed to analyze trials, and begin business development.

Like EDC and clinical trial management solution makers, RedOak claims its offering will help cut the cost of clinical trials. But RedOak veers from the mainstream. It's developing a decision-modeling support platform for drug development based on Saffron Natural Intelligence associative-memory technology.

Fedewa says drug developers have yet to come to grips with how to manage the immense amount of public and proprietary data available to help interpret trial results. The RedOak solution will aid researchers with decision support and provide predictive analytics for both public and proprietary data in structured and unstructured formats.

- see the article

Suggested Articles

There's no evidence personal patient information leaked during the 11-week breach, but the same can't be said about Sangamo's own secrets.

Through a new online tracker, AllTrials names sponsors who fail to report clinical trial results on time per the FDAAA Final Rule.

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.